 Life Science Investor Mandates
(Aug. 18
- Aug. 24)
|
|
|
|
Invests in Clinical-Stage Drugs & Marketed Devices
|
Seeks Therapeutics in Cardiology, Metabolism, Oncology, and CNS
|
|
Seeks Disruptive Innovations in Synthetic Biology, AI and Molecular Data Science
|
|
Looking for Healthcare IT Deals
|
|
|
|
The momentum of cross-border investment from Asian countries such as China, Japan, and Korea continues to grow. China has picked up steam in overseas M&A with $122.57 billion in deal value in just the first half of 2016, shattering its record and surpassing that of the US and Germany.
The LSN team regularly travels to major innovation hubs in North America, from Boston and San Francisco to Houston and Toronto. Everywhere we go, we are seeing a growing number of Asian investors and corporations in search of innovative healthcare products. The healthcare sector has become increasingly attractive for its long-term growth as well as solutions to the buyer's domestic unmet medical needs.
The cross-border investment scene not only has seen quantitative changes, but qualitative ones. A decade ago, only a small number of state-owned entities or large corporations went outbound to acquire strategic resources...
|
 |
|
Boston is known for being the hub of the biotech world. But as software is eating the world, innovators are finding new avenues for digitization of healthcare. Some are tackling inefficiencies and bottlenecks in the healthcare delivery system; others are using big data algorithms to explore biological processes, make new discoveries, or find new signals in population health data.
RESI Boston will feature two panels that explore this collision between software and health. The Healthcare IT session will look at the current landscape in digital health investment. What kind of solutions are investors excited about, and how do they assess startups in this increasingly crowded sector?
Moderated by
Michael A. Greeley, General Partner, Flare Capital Partners, the panelists are:
- Aaron Nelson, General Partner, dRx Capital
- Bob Saunders, General Partner, OCA Ventures
- Dr David Kim, CEO, DigiTx Partners LLC
- Drew Volpe, Partner, Procyon Ventures
In Big Data in Healthcare, RESI will take a laser focused look at the new possibilities that data science is creating in biotech and health innovation. Five investors will explore what they're looking for in a big data opportunity. The participants will be:
- Alex de Winter, Director, GE Ventures
- Allyson Plosko, Manager of Health, Village Capital
- Annie Hazelhurst, Founder, Faridan
- Dylan Morris, Investment Team, Innovation Endeavours
- Linda Pan, Program Director, Strategic Solutions, Watson Health at IBM
|
|
By Nono Hu, Director of Marketing, LSN
This week, the LSN Summer Reading Series covers one of the most powerful tools in your fundraising arsenal: the outreach email.
From basics like mail merging and segmenting your list to sophisticated tools such as delivery scheduling and analytical tracking, this chapter covers how to use email to introduce your company to an audience of potential investors. This chapter also explains the importance of targeting the right contacts when you send an email and of including clickable links in order to uncover which recipients are engaging with your message...
|
|
|
